Found: 43
Select item for more details and to access through your institution.
Chromatographic separation of silver-111 from neutron-irradiated palladium target: toward direct labeling of radiotracers.
- Published in:
- EJNMMI Radiopharmacy & Chemistry, 2023, v. 8, n. 1, p. 1, doi. 10.1186/s41181-023-00232-0
- By:
- Publication type:
- Article
Microfluidic-based production of [<sup>68</sup>Ga]Ga-FAPI-46 and [<sup>68</sup>Ga]Ga-DOTA-TOC using the cassette-based iMiDEV™ microfluidic radiosynthesizer.
- Published in:
- EJNMMI Radiopharmacy & Chemistry, 2023, v. 8, n. 1, p. 1, doi. 10.1186/s41181-023-00229-9
- By:
- Publication type:
- Article
Optimized, automated and cGMP-compliant synthesis of the HER2 targeting [<sup>68</sup>Ga]Ga-ABY-025 tracer.
- Published in:
- EJNMMI Radiopharmacy & Chemistry, 2023, v. 8, n. 1, p. 1, doi. 10.1186/s41181-023-00226-y
- By:
- Publication type:
- Article
Metallacages with 2,6-dipicolinoylbis(N,N-dialkylthioureas) as novel platforms in nuclear medicine for <sup>68</sup>Ga, <sup>177</sup>Lu and <sup>198</sup>Au.
- Published in:
- EJNMMI Radiopharmacy & Chemistry, 2023, v. 8, n. 1, p. 1, doi. 10.1186/s41181-023-00225-z
- By:
- Publication type:
- Article
The Curies' element: state of the art and perspectives on the use of radium in nuclear medicine.
- Published in:
- EJNMMI Radiopharmacy & Chemistry, 2023, v. 8, n. 1, p. 1, doi. 10.1186/s41181-023-00220-4
- By:
- Publication type:
- Article
Proceedings of international symposium of trends in radiopharmaceuticals 2023 (ISTR-2023).
- Published in:
- EJNMMI Radiopharmacy & Chemistry, 2023, v. 8, n. 1, p. 1, doi. 10.1186/s41181-023-00224-0
- By:
- Publication type:
- Article
Evaluation of the <sup>177m</sup>Lu-concentration in in-house produced <sup>177</sup>Lu-radiopharmaceuticals and commercially available Lutathera<sup>®</sup>.
- Published in:
- EJNMMI Radiopharmacy & Chemistry, 2023, v. 8, n. 1, p. 1, doi. 10.1186/s41181-023-00222-2
- By:
- Publication type:
- Article
<sup>89</sup>Zr-leukocyte labelling for cell trafficking: in vitro and preclinical investigations.
- Published in:
- EJNMMI Radiopharmacy & Chemistry, 2023, v. 8, n. 1, p. 1, doi. 10.1186/s41181-023-00223-1
- By:
- Publication type:
- Article
Highlight selection of radiochemistry and radiopharmacy developments by editorial board.
- Published in:
- EJNMMI Radiopharmacy & Chemistry, 2023, v. 8, n. 1, p. 1, doi. 10.1186/s41181-023-00218-y
- By:
- Publication type:
- Article
Bacterial survival in radiopharmaceutical solutions: a critical impact on current practices.
- Published in:
- EJNMMI Radiopharmacy & Chemistry, 2023, v. 8, n. 1, p. 1, doi. 10.1186/s41181-023-00221-3
- By:
- Publication type:
- Article
Dosimetry of [<sup>18</sup>F]TRACK, the first PET tracer for imaging of TrkB/C receptors in humans.
- Published in:
- EJNMMI Radiopharmacy & Chemistry, 2023, v. 8, n. 1, p. 1, doi. 10.1186/s41181-023-00219-x
- By:
- Publication type:
- Article
Synthesis and evaluation of a novel PET ligand, a GSK'963 analog, aiming at autoradiography and imaging of the receptor interacting protein kinase 1 in the brain.
- Published in:
- EJNMMI Radiopharmacy & Chemistry, 2023, v. 8, n. 1, p. 1, doi. 10.1186/s41181-023-00217-z
- By:
- Publication type:
- Article
TrisOxine abiotic siderophores for technetium complexation: radiolabeling and biodistribution studies.
- Published in:
- EJNMMI Radiopharmacy & Chemistry, 2023, v. 8, n. 1, p. 1, doi. 10.1186/s41181-023-00214-2
- By:
- Publication type:
- Article
Synthesis and evaluation of a novel PET ligand, a GSK'963 analog, aiming at autoradiography and imaging of the receptor interacting protein kinase 1 in the brain.
- Published in:
- EJNMMI Radiopharmacy & Chemistry, 2023, v. 8, n. 1, p. 1, doi. 10.1186/s41181-023-00217-z
- By:
- Publication type:
- Article
Fully automated radiolabeling of [<sup>68</sup>Ga]Ga-EMP100 targeting c-MET for PET-CT clinical imaging.
- Published in:
- EJNMMI Radiopharmacy & Chemistry, 2023, v. 8, n. 1, p. 1, doi. 10.1186/s41181-023-00213-3
- By:
- Publication type:
- Article
State of the art procedures towards reactive [<sup>18</sup>F]fluoride in PET tracer synthesis.
- Published in:
- EJNMMI Radiopharmacy & Chemistry, 2023, v. 8, n. 1, p. 1, doi. 10.1186/s41181-023-00203-5
- By:
- Publication type:
- Article
Novel radionuclides for use in Nuclear Medicine in Europe: where do we stand and where do we go?
- Published in:
- EJNMMI Radiopharmacy & Chemistry, 2023, v. 8, n. 1, p. 1, doi. 10.1186/s41181-023-00211-5
- By:
- Publication type:
- Article
Good practices for the automated production of <sup>18</sup>F-SiFA radiopharmaceuticals.
- Published in:
- EJNMMI Radiopharmacy & Chemistry, 2023, v. 8, n. 1, p. 1, doi. 10.1186/s41181-023-00215-1
- By:
- Publication type:
- Article
Au@<sup>109</sup>Pd core–shell nanoparticle conjugated to trastuzumab for the therapy of HER2+ cancers: studies on the applicability of <sup>109</sup>Pd/<sup>109m</sup>Ag in vivo generator in combined β<sup>−</sup> auger electron therapy
- Published in:
- EJNMMI Radiopharmacy & Chemistry, 2023, v. 8, n. 1, p. 1, doi. 10.1186/s41181-023-00212-4
- By:
- Publication type:
- Article
[<sup>225</sup>Ac]Ac- and [<sup>111</sup>In]In-DOTA-trastuzumab theranostic pair: cellular dosimetry and cytotoxicity in vitro and tumour and normal tissue uptake in vivo in NRG mice with HER2-positive human breast cancer xenografts.
- Published in:
- EJNMMI Radiopharmacy & Chemistry, 2023, v. 8, n. 1, p. 1, doi. 10.1186/s41181-023-00208-0
- By:
- Publication type:
- Article
Imaging of fibrogenesis in the liver by [<sup>18</sup>F]TZ-Z09591, an Affibody molecule targeting platelet derived growth factor receptor β.
- Published in:
- EJNMMI Radiopharmacy & Chemistry, 2023, v. 8, n. 1, p. 1, doi. 10.1186/s41181-023-00210-6
- By:
- Publication type:
- Article
Development of [<sup>225</sup>Ac]Ac-DOTA-C595 as radioimmunotherapy of pancreatic cancer: in vitro evaluation, dosimetric assessment and detector calibration.
- Published in:
- EJNMMI Radiopharmacy & Chemistry, 2023, v. 8, n. 1, p. 1, doi. 10.1186/s41181-023-00209-z
- By:
- Publication type:
- Article
Reducing kidney uptake of radiolabelled exendin-4 using variants of the renally cleavable linker MVK.
- Published in:
- EJNMMI Radiopharmacy & Chemistry, 2023, v. 8, n. 1, p. 1, doi. 10.1186/s41181-023-00206-2
- By:
- Publication type:
- Article
First-in-human study of a novel cell death tracer [<sup>99m</sup>Tc]Tc-Duramycin: safety, biodistribution and radiation dosimetry in healthy volunteers.
- Published in:
- EJNMMI Radiopharmacy & Chemistry, 2023, v. 8, n. 1, p. 1, doi. 10.1186/s41181-023-00207-1
- By:
- Publication type:
- Article
In vitro characterisation of [<sup>177</sup>Lu]Lu-DOTA-C595 as a novel radioimmunotherapy for MUC1-CE positive pancreatic cancer.
- Published in:
- EJNMMI Radiopharmacy & Chemistry, 2023, v. 8, n. 1, p. 1, doi. 10.1186/s41181-023-00204-4
- By:
- Publication type:
- Article
Evaluation of the pharmacokinetics, dosimetry, and therapeutic efficacy for the α-particle-emitting transarterial radioembolization (αTARE) agent [<sup>225</sup>Ac]Ac-DOTA-TDA-Lipiodol<sup>®</sup> against hepatic tumors.
- Published in:
- EJNMMI Radiopharmacy & Chemistry, 2023, v. 8, n. 1, p. 1, doi. 10.1186/s41181-023-00205-3
- By:
- Publication type:
- Article
The DOTA macrocyclic cavity in metallic radiopharmaceuticals: Mythology or reality?
- Published in:
- EJNMMI Radiopharmacy & Chemistry, 2023, v. 8, n. 1, p. 1, doi. 10.1186/s41181-023-00202-6
- By:
- Publication type:
- Article
EJNMMI Radiopharmacy and Chemistry obtains its first impact factor!!
- Published in:
- EJNMMI Radiopharmacy & Chemistry, 2023, v. 8, n. 1, p. 1, doi. 10.1186/s41181-023-00201-7
- By:
- Publication type:
- Article
Simplified and highly-reliable automated production of [<sup>18</sup>F]FSPG for clinical studies.
- Published in:
- EJNMMI Radiopharmacy & Chemistry, 2023, v. 8, n. 1, p. 1, doi. 10.1186/s41181-023-00200-8
- By:
- Publication type:
- Article
Automated radiosynthesis and in vivo evaluation of <sup>18</sup>F-labeled analog of the photosensitizer ADPM06 for planning photodynamic therapy.
- Published in:
- EJNMMI Radiopharmacy & Chemistry, 2023, v. 8, n. 1, p. 1, doi. 10.1186/s41181-023-00199-y
- By:
- Publication type:
- Article
First preclinical evaluation of [<sup>225</sup>Ac]Ac-DOTA-JR11 and comparison with [<sup>177</sup>Lu]Lu-DOTA-JR11, alpha versus beta radionuclide therapy of NETs.
- Published in:
- EJNMMI Radiopharmacy & Chemistry, 2023, v. 8, n. 1, p. 1, doi. 10.1186/s41181-023-00197-0
- By:
- Publication type:
- Article
Abstracts from the 20th European symposium on radiopharmacy and radiopharmaceuticals.
- Published in:
- EJNMMI Radiopharmacy & Chemistry, 2023, v. 8, n. 1, p. 1, doi. 10.1186/s41181-023-00193-4
- Publication type:
- Article
Intravenous and oral whole body ketone dosimetry, biodistribution, metabolite correction and kinetics studied by (R)-[1-<sup>11</sup>C]β-hydroxybutyrate ([<sup>11</sup>C]OHB) PET in healthy humans.
- Published in:
- EJNMMI Radiopharmacy & Chemistry, 2023, v. 8, n. 1, p. 1, doi. 10.1186/s41181-023-00198-z
- By:
- Publication type:
- Article
Optimization of <sup>177</sup>Lu-labelling of DOTA-TOC, PSMA-I&T and FAPI-46 for clinical application.
- Published in:
- EJNMMI Radiopharmacy & Chemistry, 2023, v. 8, n. 1, p. 1, doi. 10.1186/s41181-023-00196-1
- By:
- Publication type:
- Article
Membrane-based microfluidic solvent extraction of Ga-68 from aqueous Zn solutions: towards an automated cyclotron production loop.
- Published in:
- EJNMMI Radiopharmacy & Chemistry, 2023, v. 8, n. 1, p. 1, doi. 10.1186/s41181-023-00195-2
- By:
- Publication type:
- Article
Site-specific <sup>68</sup>Ga-labeled nanobody for PET imaging of CD70 expression in preclinical tumor models.
- Published in:
- EJNMMI Radiopharmacy & Chemistry, 2023, v. 8, n. 1, p. 1, doi. 10.1186/s41181-023-00194-3
- By:
- Publication type:
- Article
Improved quality control of [<sup>177</sup>Lu]Lu-PSMA I&T.
- Published in:
- EJNMMI Radiopharmacy & Chemistry, 2023, v. 8, n. 1, p. 1, doi. 10.1186/s41181-023-00191-6
- By:
- Publication type:
- Article
Highlight selection of radiochemistry and radiopharmacy developments by editorial board.
- Published in:
- EJNMMI Radiopharmacy & Chemistry, 2023, v. 8, n. 1, p. 1, doi. 10.1186/s41181-023-00192-5
- By:
- Publication type:
- Article
Synthesis of [<sup>18</sup>F]FMISO, a hypoxia-specific imaging probe for PET, an overview from a radiochemist's perspective.
- Published in:
- EJNMMI Radiopharmacy & Chemistry, 2023, v. 8, n. 1, p. 1, doi. 10.1186/s41181-023-00190-7
- By:
- Publication type:
- Article
Automated synthesis and quality control of [<sup>68</sup>Ga]Ga-PentixaFor using the Gaia/Luna Elysia-Raytest module for CXCR4 PET imaging.
- Published in:
- EJNMMI Radiopharmacy & Chemistry, 2023, v. 8, n. 1, p. 1, doi. 10.1186/s41181-023-00187-2
- By:
- Publication type:
- Article
Scale down and optimized automated production of [68Ga]68Ga-DOTA-ECL1i PET tracer targeting CCR2 expression.
- Published in:
- EJNMMI Radiopharmacy & Chemistry, 2023, v. 8, n. 1, p. 1, doi. 10.1186/s41181-023-00188-1
- By:
- Publication type:
- Article
Radiosynthesis and preclinical evaluation of [<sup>11</sup>C]SNX-ab as an Hsp90α,β isoform-selective PET probe for in vivo brain and tumour imaging.
- Published in:
- EJNMMI Radiopharmacy & Chemistry, 2023, v. 8, n. 1, p. 1, doi. 10.1186/s41181-023-00189-0
- By:
- Publication type:
- Article
Good practices for Ga-68 radiopharmaceutical production: an important correction.
- Published in:
- EJNMMI Radiopharmacy & Chemistry, 2023, v. 8, n. 1, p. 1, doi. 10.1186/s41181-022-00184-x
- By:
- Publication type:
- Article